They are using a multi drug combination of Venetoclax which was developed in the 1980s and Retuximab or Ibrutinib which is doubling the survival rates of patients with Lymphocytic leukaemia and mantle cell Lymphoma.No chemo and no side effects.Its not a cure but is halving the death rate of these cancers.
- Forums
- ASX - By Stock
- IMU
- Imugene Small Caps Presentation
IMU
imugene limited
Add to My Watchlist
0.00%
!
13.5¢
Imugene Small Caps Presentation, page-81
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
